DailyIQ
|
Last updated3 minutes ago

AHR·American Healthcare REIT Inc.

$52.42
-0.11 (-0.21%)
Overnight$52.42+0.00 (+0.00%)
High
$53.14
Open
$52.46
Market Cap
11.53B
52W High
$59.50
Low
$51.91
P. Close
$52.42
P/E
95.29
52W Low
$41.38
Fwd P/E
53.06
DailyIQ Est.
$66.12
Inst. Ownership
49.6%
Short Interest
14.49%
Days to Cover
8.6
Div. Yield
1.91%
Next Ex-Div
~Dec 31
NewEarnings release, scored · filed Aug 6, 2026Guidance raised · tone -0.5 vs prior release · 83 lines scoredSee the breakdown
Technical Score (1D)
76
BULLISH
News Sentiment
61
BULLISH
On Oct 13, Raymond James analyst David Rodgers initiated coverage of American Healthcare REIT, issuing a Strong Buy rating and setting a price target of $62. Rodgers highlighted the REIT’s robust portfolio of senior housing and skilled nursing facilities, noting that the properties generate stable cash flows. He also pointed to recent dividend growth and disciplined capital allocation as factors supporting the upside thesis. The rating and target suggest a bullish outlook for the REIT’s valuation relative to industry peers. No other developments were reported for that date.
LOW TARGET
$55 +4.9%
2 analysts
MEAN TARGET
$64 +21.7%
6 analysts
HIGH TARGET
$74 +41.2%
13 analysts
PRICE RANGE
$55.00 - $74.00
SB / B / H / S / SS
7/11/1/1/1
DAILYIQ EST.
$66.12 (+26.1%)
Bought (1Y)
0 shares
$0
Sold (1Y)
120,891 shares
$6.7M
Foster Mark E.EVP, GC & Secretary
Sell1,500 shares2026-09-25
Foster Mark E.EVP, GC & Secretary
Sell2,000 shares2026-09-01
Prosky Danny-
Option Exercise20,912 shares2026-07-21
Prosky Danny-
Option Exercise30,886 shares2026-07-21
Prosky Danny-
Award/Grant2,594 shares2026-07-21
View full insider trading history →
73/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
3.3%
Return on Equity
2.1%
View full financials →

EPS

EstBeatMiss
$0.14$0.17$0.21$0.25$0.29Q3'25Q3'26
QtrEstActual+/−
Q3'26$0.16 - -
Q3'25$0.15$0.27+74.9%

Revenue

EstBeatMiss
$552M$597M$643M$689M$734MQ3'25Q3'26
QtrEstActual+/−
Q3'26$713M - -
Q3'25 - $573M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

AHR Stock Snapshot

BULLISH76/100
$52.42+$0.00 (0.0%)
Market cap
11.53B
P/E ratio
95.3
Day range
$51.91 – $53.14
News sentiment
61/100 · Bullish
Analyst target
$63.80 (+21.7%)
Consensus
Buy · 21 analysts
52-week range+26.7% off low · -11.9% from high
$41.38$59.50
Price $52.42 DailyIQ Est. $66.12

The signal on AHR is bullish: price action is confirming the underlying trend, not fighting it. The stock is liquid enough that positioning changes get absorbed without distorting the trend.

Behaviour On Record

What AHR's own history says about today's numbers

Realized volatility (21d)
23.6% 16th pct
vs 200-day average
+2.6%
Up days (1y)
52%

American Healthcare REIT Inc. is currently running 23.6% annualised volatility over the last 21 sessions. Measured against AHR's own 3 years of daily returns rather than a market-wide average, that is the 16th percentile — unusually subdued by its own history, against a typical reading of 31.0%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

Price sits +2.6% from its 200-day moving average. Against every other day in its history, that gap ranks at the 6th percentile — a narrower gap than it typically runs. Over the past year AHR closed higher on 52% of sessions, and it is currently 1 session into a falling streak.

Overnight risk is measurable too: AHR has opened more than 2% away from the prior close in 91 of 673 sessions (13.5% of the time), with the largest gaps running +44.0% and -10.2%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

All figures computed from 674 daily closes between 2024-02-07 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against AHR's own 3-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of AHR's sector?

American Healthcare REIT Inc. sits in the Real Estate sector, currently ranked 11th of 12 GICS sectors by relative-strength rotation score (improving).

Sector rank
#11 of 12
Sector state
Improving
Sector rotation score
27

Options Market

What is the options market pricing for AHR?

CallsPuts

For American Healthcare REIT Inc.'s nearest expiry (2026-10-16, 2 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.53), with at-the-money implied volatility around 135.4%. The options market is pricing roughly a ±9.1% move by that expiry — a range of about $47.16–$56.64.

Put/call ratio (2026-10-16)
0.53
ATM implied volatility
135.4%
Total open interest
698
Expected move by 2026-10-16
±9.1% ($47.16–$56.64)

Analyst Rating Changes

Are analysts turning bullish or bearish on AHR?

UBS most recently reiterated its rating on American Healthcare REIT Inc. to Buy on Oct 13, 2026 with a price target of $62 (from $63). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
UBS — Buy
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Oct 13, 2026UBSMaintainedBuy$63 → $62
Oct 13, 2026BarclaysMaintainedOverweight$66 → $60
Oct 13, 2026Raymond JamesInitiatedStrong Buy$62
Sep 2, 2026ScotiabankMaintainedSector Outperform$56 → $62
Aug 31, 2026BarclaysMaintainedOverweight$61 → $66
Aug 19, 2026KeybancMaintainedOverweight$58 → $68
Aug 14, 2026Truist SecuritiesMaintainedBuy$57 → $61
Aug 14, 2026RBC CapitalMaintainedOutperform$56 → $61
Aug 13, 2026CitigroupMaintainedBuy$55 → $65
Jul 27, 2026CitizensMaintainedMarket Outperform$60 → $65
Jul 21, 2026Compass PointInitiatedBuy$70
Jul 8, 2026UBSMaintainedBuy$60 → $63

Earnings Release, Scored

What did American Healthcare REIT Inc.'s latest earnings release say?

Filed Aug 6, 2026 · SEC Form 8-K, Exhibit 99

Guidance raised
Tone59.4/ 100-0.5 vs prior release
Hedging words1.83per 100 words+0.43 vs prior release
Tone, last 2 releasesScale 50–70

Most important lines

  1. 1

    "With strong results in the first half and expectation of carrying that momentum through the second half we are raising full-year guidance for both NFFO per diluted share and Same-Store NOI growth," said Chief Financial Officer Brian Peay.

    Guidance raisedNew this quarter
  2. 2

    The Company is increasing total portfolio Same-Store NOI growth guidance to 11.0% to 13.0% and NFFO per diluted share guidance to $2.15 to $2.19 for the year ending December 31, 2026, over a 5% increase versus the prior NFFO per diluted share guidance at the midpoint.

    Guidance raised
  3. 3

    "NFFO per diluted share is now expected to be between $2.15 to $2.19 in 2026, which would translate to over 25% per share growth versus 2025.

    New this quarter

Scores describe the release's wording. They are not a forecast.

Read all 83 scored lines →

ETF holders

ETFs holding AHR

Top ETF holdersWeight

News Sentiment Analysis

Sentiment gathered from recent headlines

61/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Raymond James analyst David Rodgers initiated coverage of American Healthcare REIT (AHR) on October 13, issuing a Strong Buy rating and setting a price target of $62. The firm highlighted AHR’s robust portfolio of senior housing and skilled nursing facilities, citing stable cash flows and a favorable demographic trend. Rodgers noted that AHR’s recent dividend growth and disciplined capital allocation support the upside thesis. The rating and target suggest a bullish outlook for the REIT’s valuation relative to peers.
What did this article say?
American Healthcare REIT (AHR) fell 7.8% over the previous month, but technical analysis indicates the stock is now oversold. Analysts largely agree that AHR could report earnings that exceed earlier forecasts, suggesting a potential rebound. The company’s fundamentals and market positioning support a modest upside as selling pressure subsides.
What did this article say?
American Healthcare REIT (AHR) achieved a Zacks Rank of #2 (Buy) in October 2022, placing it among the top performers in the Finance sector. Analysts noted a 5.6% increase in the consensus full‑year earnings estimate over the previous three months, indicating improving sentiment. The company’s position at #6 in the sector rank reflects its relative strength compared to 890 peers. The positive earnings outlook suggests potential upside for investors, though the impact is moderate and already partially priced.
What did this article say?
American Healthcare REIT (AHR) was highlighted as a favorable investment due to rising senior‑care housing demand and outpatient service expansion, which are expected to lift funds from operations (FFO) and net operating income (NOI). The analysis noted that these sector tailwinds support a sustainable dividend and provide long‑term upside potential. The article emphasized that AHR’s current valuation reflects these growth drivers, positioning the stock as a buy for investors seeking exposure to the healthcare real‑estate sector.
What did this article say?
American Healthcare REIT, Inc. (AHR) announced the schedule for its third quarter 2026 earnings release and accompanying conference call. The earnings report will be issued on November 5, 2026, after market close, with a public call and webcast on November 6, 2026. Executives will review results, discuss recent events, and answer investor questions during the call. The announcement provides investors with the timing of financial disclosures but does not indicate any change to guidance or performance expectations.
What did this article say?
American Healthcare REIT (AHR) is highlighted by Zacks Equity Research as a compelling play due to robust demand for modern healthcare properties, despite broader REIT headwinds such as higher interest rates and construction costs. The analysis notes that AHR’s portfolio is well-positioned with strong balance sheets and limited development pipeline, providing room for growth. While aging properties and tenant stress pose potential risks, the overall outlook remains positive, with AHR benefiting from a healthy demand environment across healthcare, industrial, and office markets.
What did this article say?
Zacks identifies American Healthcare REIT (AHR) as a compelling buy despite broader REIT sector headwinds from higher rates and construction costs. The firm notes AHR’s diversified portfolio across health care, industrial, lodging, office and infrastructure, which helps mitigate occupancy risks. AHR’s strong balance sheet and growth‑oriented pipeline position it to capitalize on demand for modern assets, potentially offsetting refinancing pressures.
What did this article say?
American Healthcare REIT (AHR) is highlighted as a low‑volatility, high‑quality defensive play in a market where rate uncertainty is rising. The article positions AHR alongside other stable assets, noting its income‑focused portfolio of clinical healthcare real estate. No recent earnings, guidance, or structural changes are disclosed, so the narrative remains a general positioning piece rather than a catalyst. Investors may view AHR as a ballast in a volatile environment, but the piece offers no new data that would materially shift expectations. The focus is on AHR’s role in a defensive strategy rather than on any specific financial event.

Technical Analysis

Real-time indicators across multiple timeframes

76
BULLISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $5.42B combined position · 16 adding, 9 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
BlackRock, Inc.▼ Sell25,845,94811.77%$1.35B2026-08-07
Vanguard Group Inc▲ Buy24,974,19511.38%$1.18B2026-01-29
Wellington Management Group LLP▲ Buy8,658,8503.94%$451.56M2026-08-14
Invesco Ltd.▼ Sell5,264,6672.40%$274.55M2026-08-14
FMR LLC (Fidelity)▼ Sell4,568,1912.08%$238.23M2026-08-13
Geode Capital Management, LLC▼ Sell4,563,9392.08%$238.06M2026-08-12
Bank of America Corp▲ Buy4,531,9582.06%$236.34M2026-08-14
Prudential Financial Inc▲ Buy3,640,6231.66%$189.86M2026-08-12
Capital World Investors▲ Buy2,809,7871.28%$146.53M2026-08-12
Norges Bank▲ Buy2,676,0711.22%$139.56M2026-08-12
Balyasny Asset Management L.P.▲ Buy2,631,4721.20%$137.23M2026-08-14
Morgan Stanley▲ Buy2,378,6401.08%$124.05M2026-08-13
Millennium Management LLC▲ Buy1,992,0730.91%$103.89M2026-08-14
AllianceBernstein L.P.▼ Sell2,005,0870.91%$94.56M2026-08-14
Northern Trust Corp▼ Sell1,751,1870.80%$91.32M2026-08-13
Two Sigma Investments, LP▲ Buy1,532,7100.70%$79.93M2026-08-14
Citadel Advisors LLC▲ Buy1,504,7140.69%$78.47M2026-09-02
Goldman Sachs Group Inc▼ Sell1,017,4570.46%$53.06M2026-08-14
Adage Capital Partners GP, L.L.C.▲ Buy810,0000.37%$42.24M2026-08-14
JPMorgan Chase & Co▼ Sell779,2430.35%$40.98M2026-08-12
Susquehanna International Group, LLP▲ Buy776,4850.35%$40.49M2026-08-14
Verition Fund Management LLC▲ Buy613,1220.28%$31.97M2026-08-14
Neuberger Berman Group LLC▼ Sell439,4240.20%$22.92M2026-08-13
Soros Fund Management LLC▲ New428,6300.20%$22.35M2026-08-14
Point72 Asset Management, L.P.▲ Buy408,2750.19%$21.29M2026-08-14
Q2 2026 flow:9.97M sh bought ($519.75M)8.61M sh sold ($445.02M)net +1.36M sh (+$74.73M)
View full institutional holdings history →

Discover More

ELS
Equity Lifestyle Properties Inc.
$59.61
+0.02%
KIM
Kimco Realty Corporation
$22.39
+0.00%
OHI
Omega Healthcare Investors Inc.
$45.09
-0.02%
ARE
Alexandria Real Estate Equities, Inc.
$41.69
+0.43%
IRM
Iron Mountain Incorporated
$110.86
-0.05%
VMRK
Vivmark Residential Common Shares of Beneficial Interest
$61.00
+0.28%
IYR
iShares U.S. Real Estate ETF
$95.93
+0.00%
XLRE
Real Estate Select Sector SPDR Fund
$41.53
+0.05%
EXR
Extra Space Storage Inc.
$134.08
+0.03%
DLR
Digital Realty Trust, Inc.
$176.15
+2.35%